Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04318366

COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor

Collection and analysis of demographic, clinical, radiographic and laboratory characteristics of CoViD-19 patients to identify predictors of disease severity, mortality and treatment response, and to identify subgroup of patients that might benefit from specific therapeutic interventions

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Coronavirus Infections Coronaviridae Infections Infections Nidovirales Infections RNA Virus Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

AIDS Immunopathogenesis Unit - IRCCS San Raffaele Scientific Institute, Milan, Lombardy, Italy

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients admitted to hospital with biological samples positive for SARS-CoV-2
  • Patients admitted to hospital with negative test but clinical and radiological characteristics highly suggestive of SARS-CoV-2 disease
  • Patients discharged from emergency department with biological samples positive for SARS-CoV-2

Exclusion criteria

  • None

Treatment and study plan

observational study

Other

Not required

Primary outcomes

  1. Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response

    Time frame: Hospital stay (2-3 weeks)

    Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response

Study contacts

Contact information is provided by the study sponsor or research team.

Alberto Zangrillo, Professor

CONTACT

[email protected]

+390226436151

Giovanni Landoni, Professor

CONTACT

[email protected]

+390226436151

Sponsors and collaborators

Lead sponsor

Università Vita-Salute San Raffaele

Other

Registry information

Official study title

Study to Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response

Acronym: COVID-BioB

Important dates

Study start
2020
Primary completion
2026
Study completion
2026
First posted
Mar 24, 2020
Registry last updated
May 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.